Abstract Cancer survivors engage in cancer screenings and protective health behaviors at suboptimal rates despite their increased risk for future illness. Survivorship care plans and other educational strategies to prepare cancer survivors to adopt engaged roles in managing long-term follow-up care and health risks are needed. In a sample of cancer survivors, we identified patient characteristics and psychosocial predictors associated with increased follow-up care informational needs. Cross-sectional surveys were administered to earlystage breast and prostate survivors (N=278; 68 % breast) at least 2 years post treatment from four community hospital programs in New Jersey between May 2012 and July 2013. Patient demographics, medical history, psychosocial characteristics (i.e., worries about the future, fear of disease recurrence, and patient activation), and perceptions of oncology and primary care were assessed. African-American survivors (AOR=2.69, 95 % confidence interval [CI] 1.27-5.68) and survivors with higher comorbidity (AOR=1.16, CI 1.01-1.33) were more likely to want additional information to guide follow-up care. Adjusting for race and comorbidities, survivors who wanted more information to guide their follow-up care reported greater worries about the future (p<0.05) and fears about disease recurrence (p<0.05) compared to those who did not want additional information. Results emphasize the need to develop cancer survivorship educational strategies that are both responsive to the needs of specific populations (e.g., African-American survivors and patients with multiple comorbidities) and the psychosocial profiles that motivate requests for more extensive follow-up guidance.
Introduction
There are 14.5 million cancer survivors living in the USA, with the most commonly diagnosed cancers of breast (41 %) in women and prostate (43 %) in men [1] . It is anticipated that by 2022, cancer survivor numbers will surge to exceed 18 million, and projections suggest that this group will include 12 million people who will be "longer-term" cancer survivors living at or beyond the 5 years post diagnosis mark [2] . Many cancer survivors do not optimally receive necessary cancer screenings or adopt protective health behaviors (e.g., smoking cessation, physical activity) known to prevent and detect new or recurrent disease despite their increased risks for future illnesses [3] . Further, cancer survivorship concerns appear to distract patients' attention away from focusing on their other chronic illnesses care needs [4] . This is an important consideration given that 70 % of cancer survivors have at least one additional comorbid illness [5] . Developing educational strategies to inform patients and to encourage their active participation during this phase of care is a potential lever to improve surveillance for cancer recurrence and secondary cancers, as well as to enhance the management of long-term, late effects and comorbid conditions. To date, evidence-based strategies to address this need have been lacking.
Long-term survivorship care requires three components: (1) comprehensive coordination, (2) follow-up and transitional care, and (3) ongoing discussions about care planning, coping skills, and health behavior to mitigate the long-term risks of having a cancer history and being treated for cancer [6] . However, even the early phases of post treatment (<5 year post diagnosis) are a point in care where less guidance and support is available to patients [6] . Recommendations to address this gap in care include the following: using educational tools such as survivorship care plans (SCPs) [7] , redesigning existing care models [8] , and educating and preparing the healthcare workforce [6] to enhance awareness and clinical skills to guide and support patients. Many of these strategies rely heavily on patient skills to broker care transitions despite limited preparation for patients about what they should be doing to optimize their health [9] .
Currently, the most widely promoted patient education tool to facilitate the cancer survivorship transition is the SCP, which is a comprehensive summary of cancer care and recommendations for follow-up care [6, 7] . The goals of SCPs are to enhance patient-provider and provider-provider communications in hopes that this will lead to better survivorship outcomes, including increased adherence to preventive screening and management of late and long-term effects of cancer and its treatment, including psychosocial sequelae and diagnosis [10] . Qualitative studies describe patients as wanting SCPs [11, 12] , but there is a need for additional data that supports the educational benefits of SCPs [10] . In practice, the adoption of SCPs has been slow for many reasons, including (1) resource intensity required for their development, (2) lack of provider buy-in about their utility, and (3) reimbursement issues [7, 10] . Despite the lack of an evidence base demonstrating the efficacy of SCPs in either preparing patients or facilitating communication transfer between providers [7, 10] , leading oncology professional organizations (including the American Society of Clinical Oncology and the American College of Surgeons Commission on Cancer) are in support of their adoption. Indeed, it is anticipated that SCPs will become the standard of care in the near future [10] .
Different information-seeking styles among cancer patients after an initial diagnosis are well characterized in the literature, and these styles are associated with differential adherence to medical recommendations [13] . Specifically, two coping styles-monitoring and blunting-have been shown to influence information seeking, self-management behaviors, and the psychological experience surrounding cancer information seeking post diagnosis [13] . Monitors are more active information seekers, are more likely to comply with medical advice, have more knowledge about their health conditions, and are more likely to experience psychological distress; whereas, blunters distract from information that is threatening, experience less psychological distress, and are less likely to adhere to medical recommendations [13] . It is likely that these informationseeking styles persist after treatment has ended. Therefore, it is important to understand how patient preferences influence information seeking after the treatment phase is completed.
Informational preferences are not well characterized in the literature for posttreatment cancer patients. In this study, we aim to identify patient level characteristics (i.e., sociodemographics and medical history) that motivate patients' requests for additional information to guide follow-up care. Further, we aim to delineate which psychosocial characteristics (i.e., worries about the future, fear of disease recurrence, and patient activation) and process of care factors (i.e., coordination of care, satisfaction with cancer-related information provided by oncology and primary care providers) are associated with patient desire for information to guide follow-up care. Finally, we describe the informational modalities preferred for the delivery of follow-up care guidance among the cancer survivor information seekers.
Materials and Methods

Study Participants
A total of 325 early-stage (I or II) breast and prostate cancer survivors were recruited from May 2012 to June 2013 from four community oncology hospitals that are a part of the Rutgers Cancer Institute of New Jersey's network of affiliated hospitals (CentraState Medical Center, Cooper Cancer Institute, Somerset Medical Center, The University Hospital). These institutions were chosen to reflect the diversity of this area's American College of Surgeon's accredited community oncology ambulatory care settings (e.g., community and academic). English-speaking patients, at least 2 years post active treatment (excluding hormonal maintenance therapies), for cancer at the point of recruitment were eligible for the study. Participants completed a written survey that took approximately 15 minutes to complete.
Prior to initiation, the Institutional Review Board of the Rutgers Robert Wood Johnson Medical School approved this study, and written informed consent was received from all participants. Patients were approached about the study at the time of their follow-up visit or through identification from an onsite patient registry. Patients received a survey and consent form in the mail with a cover letter from the facility where they were treated and a letter from the study principal investigator that introduced and described the study. After 2 weeks, if patients did not respond a reminder postcard was sent. After 1 month, a final survey was sent to the participant and if the participant did not return a completed survey, this was considered refusal. Site response rates averaged 60 %.
Measures
The survey instrument included items that assessed whether patients wanted additional information to guide follow-up care, socio-demographic characteristics, medical history, psychosocial characteristics, and patient perceptions of care processes. For patients who endorsed wanting additional information to guide follow-up care, preferred modalities of this information were also assessed.
Outcome Variable
The main variable of interest, desire for additional information to guide follow-up care, was measured using a single, selfreport measure to the question, "Would you like to receive information to help manage your follow-up care?" (yes/no).
Patient Characteristics and Psychosocial Factors
Socio-demographics Socio-demographic items included in the analysis were age, gender, race/ethnicity, educational attainment, employment status, and marital status. Race was dichotomized as White/Caucasian vs. Black/African-American. Educational attainment was condensed from an initial eight-item response category into high school, some college, 4-year college, or Masters/graduate school. Employment status was categorized as full-time, part-time, not employed, and retired. Marital status was collapsed into married or living with partner vs. not married. The latter category comprised those responding as single, never married, divorced, widowed, or others.
Medical History Gender was used as a proxy variable for cancer diagnosis (male = prostate and female = breast). Comorbidity was measured using the Charlson Comorbidity Index [14] . Length of time since treatment was assessed in the following phases post treatment: 2-5 years, 6-10 years, or 10+years. Type of treatment site (academic vs. community) was coded at the time of recruitment. To assess receipt of a written care summary, patients were asked if they had ever been given a written summary with the response options: yes, no, or not sure. Responses were pooled into dichotomous groups (yes vs. no/not sure) for analysis.
Psychosocial Characteristics Patient Activation is a term used to describe patient's knowledge, skills, and confidence for self-management. To assess patient activation, we used the validated, 13-item, Patient Activation Measure which has a scoring range of (0-100) [15] . Patient activation levels were calculated using established cut points [15] . Evidence supports the characterization of four levels of patient activation with progressively more engagement seen among those whose score is higher on the range of activation. Levels of patient activation are characterized as follows: At level one, patients are passive care recipients; at level two, patients may lack information but express some motivation to engage in their care processes; at level three, patients understand the basic facts but lack confidence to take action; and at level four, patients have made changes to their health but may waver in times of stress [15] .
Worries about the Future and Fear of Cancer Recurrence are two single-item questions that were used to assess worries about the future and fear of disease recurrence, respectively. Both were measured on a 5-point Likert (0=almost never to 5=almost always).
Patient Perception of Care Processes Satisfaction with cancer-related information was assessed using two singleitem frequency questions about how often cancer-related clinicians and PCPs provided as much cancer-related information as patients wanted. Possible responses available were never, sometimes, usually, and always.
Coordination of care assessed patient's perceptions of how PCPs and cancer-related clinicians received and incorporated information from other doctors into visits and patient care processes related to their follow-up. This was measured by calculating the mean for the five items on the coordination of care subscale in the Components of Primary Care Instrument [16] .
Informational Modality Preference was assessed only for cancer survivors who endorsed wanting to receive information to help manage follow-up care. This was measured using a multiple-response, forced-choice item asking how patients would want follow-up information provided, with the possible responses: website, pamphlet, smartphone application, navigator or care manager, and lecture/lunch and learn.
Statistical Analysis
Means and standard deviations (SDs) or frequencies were used to summarize survivor demographics and psychosocial factors. Logistic regression analyses assessed the association of socio-demographics and medical history with desire for more information to guide follow-up care. Backward stepwise selection identified control variables (i.e., race and comorbidity burden) that had statistically significant effects on the outcome variable (i.e., desire for follow-up information). Confirmatory analyses estimated the association of each of the other demographics, separately, with the outcome, controlling for race and comorbidity burden. Additional logistic regression models examined the psychosocial factors as predictors of desire for follow-up information. For these factors, the means (SDs) were calculated for those who do and do not desire additional information. Statistical significance was assessed at an alpha of 0.05. The analysis was carried out in SAS® Version 9.3. Percentages summarized the format by which cancer survivors preferred to get additional information, among those who desired it. Responses from 325 participants were available for this analysis. Of the 325 participants, 47 in total were excluded from the sample. Reasons for exclusion included having received treatment less than 2 years ago (n=20), not racially identifying as either African-American/Black or Caucasian/White because sample sizes were too small to meaningfully compare other racial/ethnic groups in the models (n=24), and cases missing data on the dependent variable (n=3). Thus, the final sample included 278 cancer survivors.
Results Table 1 presents the demographic characteristics of the participants. This study included more (68 %) female breast cancer survivors than male (32 %) survivors of prostate cancer. Most participants were married (71 %), and the average age of our sample was 64 years old (SD=10.8). All participants reported achieving at minimum of a high school education or GED (26 %), almost one third (30 %) of some college, one fifth (21 %) of a 4-year degree, and nearly a quarter (23 %) of having a masters or graduate degree. A majority of the sample was White/Caucasian (86 %), the remainder self-identified as African-American/Black race (14 %). Most of the sample was either retired (47 %) or not currently employed (14 %). Almost one-third of participants reported working full-time (30 %) with a smaller group (9 %) who reported working only part-time. Most of our sample was recruited from academic cancer centers (64 %) with the remainder recruited from community cancer centers (38 %). Most of the survivors Table 2 displays the results for the logistic regression models, adjusted for race and comorbidity. African-American/Black respondents were more likely (adjusted odds ratio [AOR]=2.69, p=0.01) than Caucasians/Whites to want additional follow-up information. Respondents reporting more comorbid health conditions were more likely (AOR=1.16, p=0.03) to endorse wanting additional follow-up care than those reporting less comorbidities. No other demographic or physical health factors were associated with desire for additional information to guide follow-up care. Table 3 displays the means (M) of the psychosocial and perceptions of care variables for those who wanted and did not want additional follow-up information, along with p values from the corresponding logistic regression models, adjusting for race and comorbidities. Reporting worries about the future was predictive of wanting additional information (p=0.005), with a higher mean (M=2.64, SD=1.10) among those who wanted follow-up information than among those who did not (M=2.24, SD=1.07). Fear of cancer recurrence was also predictive (p=0.04) with a higher mean among those who wanted additional follow-up information (M=3.03, SD=0.97) than among those who did not (M=2.75, SD=1.96). Neither patient ratings of care for PCP and oncologist nor satisfaction with cancer information provided by the PCPs or oncologists were significant predictors of wanting more information when controlling for race and comorbidities. Further, patient activation level was not a significant predictor for desiring additional information when entered into the logistical regression models as a categorical variable by level of activation or in the general linear model as a continuous variable, when controlling for race and comorbidities.
Among the 141 participants who reported that they wanted to receive information to manage follow-up care, the preferred information formats were website (30 %) and informational pamphlets (30 %). Fewer survivors preferred lectures or "lunch and learn" formats (18 %), patient navigators (12 %), or phone applications (4 %).
Discussion
This study aimed to delineate the patient level factors that motivate requests for information to guide follow-up care with the ultimate goal of informing the assessment and tailoring of cancer educational programs for cancer survivors. The results suggest that two specific populations of survivors-AfricanAmericans and patients with more comorbidity-were more likely to request additional information to guide follow-up.
To date, the emphasis on tailoring educational messages for African-American cancer survivors has focused largely on female breast cancer patients to the exclusion of men and those with other cancer sites. Additionally, much of that breast cancer literature has focused on the acceptability of SCPs among patients. In general, these studies report that AfricanAmerican breast cancer survivors are receptive to receiving SCPs. However, it remains unclear whether these tools would be helpful in overcoming the challenges described by AfricanAmerican breast cancer survivors [11, 17, 18] . For example, in one qualitative study, African-American breast cancer survivors expressed concerns about the use of difficult to understand technical jargon in SCPs and expressed that cautionary messages in SCPs about limiting specific imaging tests were viewed as a form of medical rationing [11] . Further, in another study, African-American breast cancer survivors described complex concerns that could not be solved by the delivery of an SCP, including (1) worries about access to care (e.g., loss of insurance benefits) and care quality due to race, (2) mistrust in research protections for African-Americans that act as a barrier to clinical trial participation, and (3) cultural taboos around disclosing cancer history to members in their community [18] . One study described the tailoring of health information for African-American breast survivors based on population health risks and recommended that SCPs need to be adapted to more extensively cover health history and comorbidity management due to their known contribution to increased morbidity and mortality [17] . No studies were found in the literature about prostate cancer patients' perspectives on survivorship care plans or post treatment preparation. This absence in the literature is consistent with the underrepresentation of African-American men in research, including clinical trials [19] . There is a need to explore informational needs and preferences generally in this population, and identify the concerns specific to AfricanAmerican prostate survivors to inform the development of targeted survivor educational materials. Further, inadequately tailored informational and educational resources for AfricanAmerican men have the potential to become a point of disparity if future work does not identify methods to tailor these materials [17, 20] .
Consistent with the existing literature, cancer survivors with a history of breast and prostate cancer and comorbid illnesses are more likely to want information to guide follow-up care. An earlier study focused on patients with a history of leukemia, colorectal, or non-Hodgkin's lymphoma similarly identified increased informational needs among both African-Americans and those with more comorbid health issues [20] . In the present study, we found that AfricanAmerican race and patients with more comorbid illness were predictive of wanting information to guide follow-up care. Survivors with comorbid illness have complex care needs. Not surprisingly, they have a greater need to understand how to mitigate their long-term medical risks. Although there are no clear guidelines about adjusting standard cancer therapies due to the presence of comorbid conditions, it is clear that this happens at the practice level for both breast and prostate cancer patients [21, 22] . However, it has been difficult to amass the evidence to formulate guidelines given the complex and overlapping factors (e.g., aging, sex, different clusters of comorbidities) [23] , which also makes the task of educating patients about their role in self managing their health more challenging. Further research is needed to identify best practices in tailoring information to guide follow-up care among patients with higher comorbidity burdens.
After controlling for race and comorbidities, we found significant differences in preference for additional follow-up information among those who had more worries about the future and fears about disease recurrence. Therefore, those patients who were more concerned and fearful about their future and cancer recurrence were more likely to seek or request more information to help them navigate this phase of care.
Further research to understand how these recurrence worries about the future are related to coping styles and informational preferences in the posttreatment cancer survivor are needed. Our findings are consistent with this body of work, which suggests that patients who are more worried and fearful about their illness are also more active seekers of information that can help them to manage this threat [13] . Based on this work, recommendations to tailor information based on coping style in cancer patients during the treatment phase have been shown to benefit patients psychologically, behaviorally, and physiologically [13] . Research to understand how this extends in the post treatment phase may have important clinical implications. There is currently an emphasis in practice on the implementation of distress screening and SCPs, and future research would illuminate if these efforts could be strengthened by more sensitive assessments that also consider the relationships between information-seeking, coping style and distress management. This study has several limitations that should be considered in interpreting the findings. First, this is a cross-sectional design using a sample of cancer survivors with wide ranges in length of survivorship, and it is likely that the informational needs of survivors may change over time. The sample was not large enough to compare these groups for this analysis. Second, due to small sample sizes of minority groups, this study was limited to comparisons between White/Caucasian and African-American/Black cancer survivors. Therefore, the findings may not generalize to other minority populations. However, these limitations notwithstanding future studies should utilize measures that are more sensitive about the different types of information that might be appropriate to guide follow-up care information to provide a broader understanding of different strategies that support patients during this phase of care.
